Half the Data, Half the Science: The Cost of Ignoring Sex Differences in Preclinical Research ++++

https://www.pharmasalmanac.com/articles/half-the-data-half-the-science-the-cost-of-ignoring-sex-differences-in-preclinical-research Bringing Clinical Trial Enrollment to the Point of Diagnosis https://www.pharmasalmanac.com/articles/bringing-clinical-trial-enrollment-to-the-point-of-diagnosis Nature’s Nanocarriers: The Evolving Role of Exosomes in Targeted Drug Delivery https://www.pharmasalmanac.com/articles/natures-nanocarriers-the-evolving-role-of-exosomes-in-targeted-drug-delivery Gene Therapy at a Crossroads: Rethinking AAV Amid Industry Resets https://www.pharmasalmanac.com/articles/gene-therapy-at-a-crossroads-rethinking-aav-amid-industry-resets